MoonLake ImmunotherapeuticsMLTXNASDAQ
Loading
ROIC: Returns DecliningContracting
Percentile Rank40
Studio
Year-over-Year Change

Return on invested capital

Latest
-64.40%
↑ 77% vs avg
Percentile
P40
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
-281.75%
Historical baseline
PeriodValueYoY Change
2025-64.40%-105.6%
2024-31.32%-199.6%
2023-10.45%+88.9%
2022-93.84%+93.7%
2021-1490.38%-1642649.1%
2020-0.09%-